Low body weight in Alzheimer's disease is associated with mesial temporal cortex atrophy

Neurology

Volumn 46, Issue 6, 1996, Pages 1585-1591

  Grundman, M ^a,c   Corey Bloom, J ^a   Jernigan, T ^b   Archibald, S ^d   Thal, L J ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d NONE

Author keywords

[No Author keywords available]

Indexed keywords

AGED; ALZHEIMER DISEASE; ARTICLE; BODY MASS; BRAIN CORTEX ATROPHY; BRAIN SIZE; CLINICAL PROTOCOL; CONTROLLED STUDY; FEEDING BEHAVIOR; FEMALE; HUMAN; LIMBIC SYSTEM; MAJOR CLINICAL STUDY; MALE; MEMORY; MORPHOMETRICS; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; TEMPORAL CORTEX; WEIGHT REDUCTION;

EID: 0029888681     PISSN: 00283878     EISSN: None     Source Type: Journal    
DOI: 10.1212/WNL.46.6.1585     Document Type: Article

References (61)

1. Berlinger WG, Potter JF. Low body mass index in demented outpatients. J Am Geriatr Soc 1991;39:973-978.
2. Burns A, Marsh A, Bender DA. Dietary intake and clinical, anthropometric and biochemical indices of malnutrition in elderly demented patients and non-demented subjects. Psychol Med 1989;19:383-391.
3. Renvall MJ, Spindler AA, Ramsdell JW, et al. Nutritional status of free-living Alzheimer's patients. Am J Med Sci 1989; 298:20-27.
4. Singh S, Mulley GP, Losowsky MS. Why are Alzheimer patients thin? Age Ageing 1988;17:21-28.
5. Sandman P, Adolfsson R, Nygren C, et al. Nutritional status and dietary intake in institutionalized patients with Alzheimer's disease and multiinfarct dementia. J Am Geriatr Soc 1987;35:31-38.
6. Aronson MK, Post DC, Guastadisegni P, et al. Weight changes and dementia. In: Corain B, Iqbal K, Nicolini M, et al., eds. Alzheimer's disease: advances in clinical and basic research. West Sussex: John Wiley & Sons, 1993:55-63.
7. Franklin CA, Karkeck J. Weight loss and senile dementia in an institutionalized elderly population. J Am Diet Assoc 1989; 89:790-792.
8. Du W, DiLuca C, Growdon J. Weight loss in Alzheimer's disease. J Geriatr Psychiatry 1993;6:34-38.
9. Andres R. Mortality and obesity: the rationale for age-specific height weight tables. In: Hazzard WR, Bierman EL, Blass JP, Ettinger WH, Halter JB, eds. Principles of geriatric medicine. New York: McGraw Hill, 1994:847-853.
10. Sullivan DH, Walls RC. Impact of nutrition status on morbidity in a population of geriatric rehabilitation patients. J Am Geriatr Soc 1994;42:471-477.
11. Potter JF, Schafer DF, Bohi RL. In-hospital mortality as a function of body mass index: an age-dependent variable. J Gerontol 1988;43:M59-M63.
12. Nielsen H, Lolk A, Pedersen I, et al. The accuracy of early diagnosis and predictors of death in Alzheimer's disease and vascular dementia - a follow-up study. Acta Psychiatr Scand 1991;84:277-282.
13. Morris CH, Hope RA, Fairburn CG. Eating habits in dementia. Br J Psychol 1989;154:801-806.
14. Mungas D, Cooper JK, Weiler PG, et al. Dietary preference for sweet foods in patients with dementia. J Am Geriatr Soc 1990; 38:999-1007.
15. Ball MJ. Topographic distribution of neurofibrillary tangles and granulovacuolar degeneration in hippocampal cortex of aging and demented patients. A quantitative study. Acta Neuropathol 1978;42:73-80.
16. Ball MJ, Hachinski V, Fox A, et al. A new definition of Alzheimer's disease: a hippocampal dementia. Lancet 1985;1:14-16.
17. Hyman BT, Van Hoesen GW, Damasio AR, Barnes CL. Alzheimer's disease: cell-specific pathology isolates the hippocampal formation. Science 1984;225:1168-1170.
18. Herzog AG, Kemper TL. Amygdaloid changes in aging and dementia. Arch Neurol 1980;37:625-629.
19. Fairburn CG, Hope RA. Changes in eating in dementia. Neurobiol Aging 1988;9:28-29.
20. Litchford MD, Wakefield LM. Nutrient intakes and energy expenditures of residents with senile dementia of the Alzheimer's type. J Am Diet Assoc 1987;87:211-213.
21. Bucht G, Sandman PO. Nutritional aspects of dementia, especially Alzheimer's disease. Age Ageing 1990;19:S32-S36.
22. McKhann G, Drachman D, Folstein M, et al. Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of the Department of Health and Human Services Task Force on Alzheimer's Disease. Neurology 1984;34:939-944.
23. Jernigan TL, Archibald S, Hesselink JR, et al. Magnetic resonance imaging morphometric analysis of cerebral volume loss in human immunodeficiency virus infection. Arch Neurol 1993;50:250-255.
24. Jernigan TL, Archibald SL, Berhow MT, et al. Cerebral structure on MRI. Part I. Localization of age related changes. Biol Psychol 1991;29:55-67.
25. Jernigan TL, Salmon PD, Butters N, et al. Cerebral structure on MRI. Part II. Specific changes in Alzheimer's disease and Huntington's disease. Biol Psychol 1991;29:68-81.
26. Mattis S. Dementia rating scale: professional manual. Odessa: Psychological Assessment Resources, 1988.
27. Folstein MF, Folstein SE, McHugh PR. Mini-Mental State: a practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 1975;12:189-202.
28. Blessed G, Tomlinson BE, Roth M. The association between quantitative measures of dementia and of senile change in the cerebral grey matter of elderly subjects. Br J Psychol 1968; 114:797-811.
29. Killiany RJ, Moss MB, Albert MS, et al. Temporal lobe regions on magnetic resonance imaging identify patients with early Alzheimer's disease. Arch Neurol 1993;50:949-954.
30. Jack CR, Peterson RC, O'Brien P, et al. MR-based hippocampal volumetry in the diagnosis of Alzheimer's disease. Neurology 1992;42:183-188.
31. Cuénod CA, Denys A, Michot JL, et al. Amygdala atrophy in Alzheimer's disease. An in vivo magnetic resonance imaging study. Arch Neurol 1993;50:941-945.
32. Jobst KA, Smith AD, Szatmari M, et al. Detection in life of confirmed Alzheimer's disease using a simple measurement of medial lobe atrophy by computed tomography. Lancet 1992; 340:1179-1183.
33. De Leon MJ, George AE, Stylopoulos LA, et al. Early marker for Alzheimer's disease: the atrophic hippocampus. Lancet 1989;2:672-673.
34. Jobst KA, Smith AD, Szatmari M, et al. Rapidly progressing atrophy of the medial temporal lobe in Alzheimer's disease. Lancet 1994;343:829-830.
35. Erkinjuntti T, Lee DH, Gao F, et al. Temporal lobe atrophy on magnetic resonance imaging in the diagnosis of early Alzheimer's disease. Arch Neurol 1993;50:305-310.
36. Pasquier F, Bail L, Lebert F, et al. Determination of medial temporal lobe atrophy in early Alzheimer's disease with computed tomography. Lancet 1994;343:861-862.
37. Kesslak JP, Nalcioglu O, Cotman CW. Quantification of magnetic resonance scans for hippocampal and parahippocampal atrophy in Alzheimer's disease. Neurology 1991;41:51-54.
38. Braak H, Braak E. Neuropathological staging of Alzheimer-related changes. Acta Neuropathol 1991;82:239-259.
39. Hyman BT, Van Hoesen GW, Damasio AR, Barnes CL. Alzheimer's disease: cell-specific pathology isolates the hippocampal formation. Science 1984;225:1168-1170.
40. Macchi G. Anatomical substrate of emotional reactions. In: Boller F, Grafman J, eds. Handbook of neuropsychology. Vol 3. New York: Elsevier Science Publishers, 1989:283-303.
41. Buckwalter JG, Schneider LS, Dunn ME, et al. Higher body weight is associated with better cognitive performance in women with probable Alzheimer's disease [abstract]. Neurology 1994;44(suppl 2):A186.
42. White H, Pieper C, Schmader K, Fillenbaum G. Weight loss in subjects with Alzheimer's disease: the CERAD experience [abstract]. Neurology 1994;44(suppl 2):A240.
43. Prentice M, Leavesley K, Murgatroyd PR, et al. Severe wasting in elderly mental patients caused by an excessive energy requirement? Age Ageing 1989;18:158-167.
44. Chui HC. Dementia: a review emphasizing clinicopathologic correlation and brain-behavior relationships. Arch Neurol 1989;46:806-814.
45. Swaab DF, Hofman MA, Lucasson PJ, et al. Functional neuroanatomy and neuropathology of the human hypothalamus. Anat Embryol 1993;187:317-330.
46. Abalon F. Alzheimer's disease and malnutrition: a new etiological hypothesis. Med Hypotheses 1984;15:385-393.
47. Bucht G, Adolfsson R, Lithner F, Winblad B. Changes in blood glucose and insulin secretion in patients with senile dementia of Alzheimer type. Acta Med Scand 1983;213:387-392.
48. Landin K, Blennow K, Wallin A, Gottfries CG. Low blood pressure and blood glucose levels in Alzheimer's disease. Evidence for a hypometabolic disorder? J Intern Med 1993;233: 357-363.
49. Manning CA, Ragozzino ME, Gold PE. Glucose enhancement of memory in patients with probable senile dementia of the Alzheimer's type. Neurobiol Aging 1993;14:523-528.
50. Weiner MF, Davis BM, Mohs RC, Davis KL. Influence of age and relative weight on cortisol suppression in normal subjects. Am J Psychiatry 1987;144:646-649.
51. Fichter MM, Pirke KM. Effect of experimental and pathological weight loss upon the hypothalamo-pituitary-adrenal axis. Psychoneuroendocrinology 1986;11:295-305.
52. Goodwin GM, Fairburn CG, Keenan JC, Cowen PJ. The effects of dieting and weight loss upon the stimulation of thyrotropin (TSH) by thyrotropin-releasing hormone (TRH) and suppression of cortisol secretion by dexamethasone in men and women. J Affect Dis 1988;14:137-144.
53. Beaumont D, Lehmann AB, James OFW. Protein turnover in malnourished elderly subjects: the effects of refeeding. Age Ageing 1989;18:235-240.
54. Sapolsky RM, Uno H, Rebert CS, Finch C. Hippocampal damage associated with prolonged glucocorticoid exposure in primates. J Neurosci 1990;10:2897-2902.
55. Davis KL, Davis BM, Greenwald BS, et al. Cortisol and Alzheimer's disease. I. Basal studies. Am J Psychiatry 1986;143: 300-305.
56. De Leon MJ, McRae T, Tsai JR, et al. Abnormal cortisol response in Alzheimer's disease linked to hippocampal atrophy. Lancet 1988;2:391-392.
57. Weiner MF, Vobach S, Svetlick D, Risser RC. Cortisol secretion and Alzheimer's disease progression: a preliminary report. Biol Psychol 1993;34:158-161.
58. Aisen PS, Davis KL. Inflammatory mechanisms in Alzheimer's disease: implications for therapy. Am J Psychiatry 1994; 151:1105-1113.
59. Fillit H, Wanhong D, Buee L, et al. Elevated circulating tumor necrosis factor levels in Alzheimer's disease. Neurosci Lett 1991;129:318-320.
60. Fillit H, Weinreb H, Cholst I, et al. Observations in a preliminary open trial of estradiol therapy for senile dementia-Alzheimer's type. Psychoneuroendocrinology 1986;11:337-345.
61. Honjo H, Ogino Y, Naitoh K, et al. In vivo effects by estrone sulfate on central nervous system-senile dementia (Alzheimer's type). J Steroid Biochem 1989;34:521-525.